Profile data is unavailable for this security.
About the company
Turk Ilac ve Serum Sanayi AS is a Turkey-based pharmaceutical company. The main activity of the Company is to manufacture and sell all kinds of tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids and other chemical substances. The company also acts as the representative or sales agency of other domestic and foreign pharmaceutical companies, as well as importing and marketing veterinary, cosmetics and pesticides. Turk Ilac manufactures in accordance with Current Good Manufacturing (GMP) and Good Laboratory Practice (GLP) principles with its approximately 300 employees in its facilities on a total area of 56.000 square meters in the Ankara - Akyurt region.
- Revenue in TRY (TTM)2.56bn
- Net income in TRY92.29m
- Incorporated2012
- Employees465.00
- LocationTurk Ilac ve Serum Sanayi ASBugduz Mah. Enver Pasa Cad. No:8 AkyurtAnkara 06750TurkeyTUR
- Phone+90 3 128376767
- Fax+90 3 128442106
- Websitehttp://www.turkilac.com.tr
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chunghwa Chemical Synthsis&Biotech CoLtd | 1.59bn | 123.93m | 3.14bn | 243.00 | 25.44 | 0.8921 | 9.63 | 1.98 | 1.51 | 1.51 | 19.37 | 43.16 | 0.3039 | 1.02 | 5.27 | -- | 2.37 | 9.03 | 2.73 | 10.56 | 32.33 | 43.26 | 7.81 | 20.15 | 0.7205 | -- | 0.2315 | 24.83 | -1.45 | 15.40 | -43.14 | 2.49 | 36.95 | -7.79 |
| Biosyent Inc | 826.06m | 174.64m | 3.17bn | 0.00 | 18.39 | 3.60 | 17.04 | 3.84 | 0.5988 | 0.5988 | 2.83 | 3.06 | 0.8352 | 1.34 | 7.74 | -- | 17.66 | 14.77 | 20.16 | 16.92 | 79.77 | 79.74 | 21.14 | 19.99 | 4.90 | -- | 0.0309 | 9.26 | 13.12 | 7.97 | 18.35 | 2.52 | -2.67 | -- |
| Bangkok Lab and Cosmetic PCL | 1.50bn | 163.74m | 3.18bn | 698.00 | 19.42 | 2.01 | 14.25 | 2.12 | 0.278 | 0.278 | 2.55 | 2.69 | 0.6961 | 2.56 | 4.73 | 2,190,737.00 | 7.81 | 6.01 | 9.71 | 13.28 | 30.74 | 27.33 | 11.22 | 5.68 | 3.08 | 16.42 | 0.1158 | -- | 8.50 | 17.54 | 15.65 | 51.84 | 19.54 | -- |
| Nectar Lifesciences Ltd | 6.70bn | 24.97m | 3.21bn | 1.69k | 128.20 | -- | 11.80 | 0.4795 | 0.275 | 0.275 | 73.96 | -- | -- | -- | -- | 9,782,218.00 | -- | -0.2956 | -- | -0.541 | 29.64 | 16.49 | 0.3725 | -0.4053 | -- | 1.06 | -- | -- | 10.53 | -9.56 | 120.66 | -36.29 | -5.06 | -- |
| Pak Fah Yeow International Ltd | 1.17bn | 425.61m | 3.22bn | 101.00 | 7.56 | 0.9705 | 7.03 | 2.75 | 0.3094 | 0.3094 | 0.8507 | 2.41 | 0.2869 | 2.84 | 23.53 | 2,600,118.00 | 10.44 | 3.99 | 11.32 | 4.18 | 87.05 | 80.79 | 36.37 | 21.27 | 4.22 | 5.26 | 0.0055 | 100.68 | 76.06 | 12.94 | 250.66 | 23.02 | 18.83 | -8.06 |
| Turk Ilac Ve Serum Sanayi AS | 2.56bn | 92.29m | 3.22bn | 465.00 | 34.87 | 1.85 | 22.13 | 1.25 | 0.5704 | 0.5704 | 15.85 | 10.77 | 0.998 | 7.39 | 2.42 | 5,842,276.00 | 3.59 | 3.05 | 5.11 | 5.26 | 31.30 | 23.44 | 3.60 | 2.36 | 1.97 | 1.16 | 0.4749 | 0.00 | 16.88 | 81.44 | 229.47 | 49.00 | 37.65 | -- |
| Biome Australia Ltd | 289.69m | -37.01m | 3.25bn | 30.00 | -- | 49.63 | -- | 11.23 | -0.0082 | -0.0082 | 0.0628 | 0.0135 | 1.65 | 2.08 | 6.06 | -- | -21.09 | -70.48 | -43.35 | -106.49 | 61.01 | 59.73 | -12.78 | -62.17 | 1.13 | -10.02 | 0.3087 | -- | 71.44 | 102.11 | 45.75 | -- | -47.07 | -- |
| Vistin Pharma ASA | 1.30bn | 188.96m | 3.30bn | 77.00 | 17.49 | 3.45 | 13.36 | 2.53 | 1.38 | 1.38 | 9.55 | 7.01 | 1.09 | 1.89 | 7.27 | 5,501,130.00 | 15.85 | 1.73 | 19.26 | 2.11 | 64.84 | 58.92 | 14.49 | 2.36 | 1.06 | 21.05 | 0.0178 | 286.16 | 51.35 | 16.95 | 1,066.84 | -- | -0.1922 | -- |
| Zhaoke Ophthalmology Ltd | 271.90m | -1.08bn | 3.33bn | 297.00 | -- | 0.3442 | -- | 12.23 | -0.4489 | -0.4489 | 0.113 | 4.01 | 0.0233 | 1.25 | 16.09 | 196,866.10 | -9.23 | -- | -10.51 | -- | 82.03 | -- | -396.86 | -- | 5.48 | -24.02 | 0.1114 | -- | -- | -- | 5.47 | -- | -- | -- |
| Merck Tbk PT | 2.02bn | 270.51m | 3.36bn | 376.00 | 12.41 | 2.12 | 9.32 | 1.66 | 278.81 | 278.81 | 2,086.21 | 1,628.52 | 1.01 | 1.61 | 6.34 | 2,396,464,000.00 | 13.54 | 12.78 | 16.05 | 18.12 | 34.90 | 40.53 | 13.36 | 14.06 | 1.70 | -- | 0.0247 | 79.25 | -14.51 | 9.46 | -0.8884 | 36.67 | -3.13 | -34.05 |
Data as of Nov 15 2024. Currency figures normalised to Turk Ilac ve Serum Sanayi AS's reporting currency: Turkish Lira TRY
0.07%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 114.64k | 0.07% |
| DFA Australia Ltd.as of 30 Sep 2024 | 320.00 | 0.00% |
| Dimensional Fund Advisors Ltd.as of 31 May 2024 | 0.00 | 0.00% |
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
